The rôle of Chlamydia trachomatis in genital-tract and associated diseases.

An application of fluorescein-conjugated monoclonal antibodies to the diagnosis of Chlamydia trachomatis infection in children.

“…Differences of the positivity rates between tissue culture and direct detection might be caused by those factors. The results also indicated that the majority of fluorescence in the clinical specimens was considered to be EB, known as extracellular form of C. trachomatis (Taylor-Robinson and Thomas 1980). Thus, the direct detection of EB with fluorescein-conjugated monoclonal antibodies was proven to be a sensitive method to detect C. trachomatis irrespective of the presence of inclusions in clinical specimens.…”

Spolno Prenosljive Okužbe Z Bakterijo Chlamydia Trachomatis V Sloveniji / Sexually Transmitted Infections With The Bacteria Chlamydia Trachomatis In Slovenia

“…Bakterija Chlamydia trachomatis (C. trachomatis) je znotrajcelična Gram-negativna bakterija (1), ki se prenaša predvsem s spolnim odnosom in povzroča okužbe urogenitalnega trakta pri moških in ženskah (2). Je najpogostejša povzročiteljica bakterijskih spolno prenosljivih okužb (SPO) v razvitem svetu (3), tudi v Sloveniji, kjer je najpogosteje prijavljena bakterijska SPO (4).…”

“…Klinično se okužba pri moških kaže predvsem kot vnetje sečnice, obmodka in mod, pri ženskah pa kot vnetje materničnega vratu, sečnice in rodil znotraj trebušne votline. V nosečnosti lahko klamidijska okužba povzroči prezgodnji razpok plodovih ovojev, novorojenčki okuženih mater pa lahko obolijo z vnetjem očesne veznice in s pljučnico (2,3). Resnično število okuženih v populaciji je težko ugotovljivo, saj urogenitalne okužbe s C. trachomatis pogosto -pri do 50% moških in do 70% žensk -potekajo brez bolezenskih znakov (5, 6) ter tako ostajajo neprepoznane in nezdravljene.…”

Post-gonococcal cervicitis and post-gonococcal urethritis. A study of their epidemiological correlation and the role of Chlamydia trachomatis in their aetiology.

“…After treatment, 13 of the 50 chlamydia-positive patients subsequently became and remained chlamydia-negative up to their last follow-up visit, which was at 2-3 weeks for four, six weeks for one, 12 weeks for three, and six months or longer for five. Thirty-seven patients remained chlamydia-positive up to the time their chlamydial infection was treated, which was at 1-2 weeks for five, [3][4][5][6] …”